Abstract 1714
Background
Despite LNETs increasing in incidence and prevalence, little data exists about natural history and response to various therapies. Management is often based on expert opinion and extrapolation from other NETS. CommNETS and NANETS undertook a rigorous consensus process to endorse and update the 2015 ENETS guidelines (1).
Methods
An endorsement approach based on the AGREE II processes (2) was undertaken by a 4 nation, 22 member CommNETS/NANETS panel, including experts from: surgery, pulmonology, medical and radiation oncology, nuclear medicine, pathology, pharmacy and patients/advocates. Two members assessed content and quality of the 52 ENETS statements using the Rigour of Development subscale. A systematic literature and abstract search since 2013 was conducted. Topic experts reviewed relevant ENETS statements and new data, using a patient-centered care perspective and a LNET-specific focus, to provide justification for endorsement or modification and to define a single important unanswered question. Statements were subsequently discussed by the entire panel at a face-to-face meeting and graded using Oxford criteria (3).
Results
230 relevant new studies were identified. Of the 20 ENETS statements relating to management strategies, 4 were endorsed, 16 modified and 3 added (see table). A set of important unanswered questions will inform future studies.Table: 1322P
| Therapy | Main change |
|---|---|
| Surgery | updated techniques for localized disease modified followup protocol expanded indication for liver cytoreduction |
| Adjuvant | not recommended |
| Locoregional | optional for slow growing disease |
| Hormone | prophylaxis of carcinoid crisis added |
| PRRT | broadened to all SSTR-expressing tumours |
| Chemotherapy | newer data on temozolomide-based regimens included |
| Targeted | evidence for everolimus upgraded new statement, not supporting use of anti-angiogenics |
| Radiotherapy | palliative use for local symptoms added |
Conclusions
Through the consensus process, guidelines for LNETS were updated to include recent evidence and practice changes. The guidelines provide clear, evidenced based statements to harmonise treatment of LNETS internationally. Refs: 1.Caplin, Ann Oncology (2015):1604-1620. 2. http://www.agreetrust.org/resource-centre/agree-ii-as-a-practice-guideline-development-framework/ (30.4.18) 3. http://www.cebm.net/index.aspx?o=5653 (30.4.18).
Clinical trial identification
Legal entity responsible for the study
Australian Gastrointestinal Trials Group.
Funding
Ipsen Pty Ltd.
Editorial Acknowledgement
Disclosure
E. Segelov: Attendeded Advisory board: Ipsen Global. Ipsen funds CommNETS through an unrestricted grant to AGITG. This work was carried out by CommNETS. There was no involvement of Ipsen in any aspect of this research. All other authors have declared no conflicts of interest.
Resources from the same session
1978 - FAM115c that upregulates proliferation and invasion under hypoxia could be a predictive biomarker for pancreatic cancer.
Presenter: Kiyoshi Saeki
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3682 - Pathologic assessment following neoadjuvant immunotherapy or chemotherapy demonstrates similar patterns in non-small cell lung cancer (NSCLC)
Presenter: Annikka Weissferdt
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3319 - Tumor-infiltrating CD3+ lymphocytes and ICOS+ T-cells predict a favorable survival in resected esophageal squamous cell carcinoma
Presenter: Min Hee Hong
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5130 - Chemokine receptor CXCR7 expression, function and clinical implications in head and neck squamous cell carcinoma
Presenter: Myung-Won Lee
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4483 - Assessment of PD-1/PD-L1 colocalization in hepatocellular carcinoma (HCC) using bright-field double labeling and quantitative digital image analysis
Presenter: Thomas Mrowiec
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1175 - Pulmonary tumor thrombotic microangiopathy (PTTM): 24 case series and its criteria for pathological diagnosis.
Presenter: Naoko Sato
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1359 - Autofluorescence: a new marker for identifying cancer stem cells (CSCs) in primary tumors
Presenter: Miriam López Gómez
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
2651 - NACC1 as a target of microRNA-331-3p regulates cell proliferation in urothelial carcinoma cells
Presenter: Kohei Morita
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
2233 - Somatic-stem transition of tumor cells is a key link in the metastasis
Presenter: Nicolai Litviakov
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
2601 - Profile of individuals who never undergo colorectal cancer screening
Presenter: Jérôme Viguier
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract